Smaller tumor size is associated with poor survival in stage II colon cancer: An analysis of 7,719 patients in the SEER database
- 1 September 2016
- journal article
- research article
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 33, 157-163
Abstract
We hypothesized that in patients with colon cancer showing heavy intestinal wall invasion without lymph node metastasis (stage II), small tumor size would correlate with more aggressive tumor behaviors and thus poorer cancer-specific survival (CSS). We analyzed Caucasian patients with stage II colon cancer based on data from the US Surveillance, Epidemiology, and End Results (SEER) database. Survival was analyzed using the Kaplan-Meier method, and the log-rank test was used to identify differences. Risk factors were analyzed using the Cox proportional hazard model. A total of 7719 stage II colon cancer patients from the SEER database were included in the analysis. The cutoff value (5.0 cm) was determined using the X-tile program. The Kaplan-Meier analysis showed that tumors <5.0 cm had a poorer CSS compared to tumors ≥5.0 cm (p = 0.006). Multivariate analysis indicated that tumor size is an independent prognostic factor for stage II patients, and compared to tumors <5.0 cm, tumors ≥5.0 cm were more likely to result in a better CSS (HR 0.775, 95% CI 0.691-0.870, p < 0.001). Tumor size was also analyzed as a continuous variable in the multivariate analysis, and the CSS decreased with decreasing tumor size (HR 0.958, 95% CI 0.936-0.981, p < 0.001). Subgroup analyses suggested that tumor size is also an independent prognostic factor for stage IIA (p = 0.002) and IIC (p < 0.001) patients. Smaller tumor size is associated with poor CSS in the stage II colon cancer and particularly in the stage IIA and IIC subgroups.Keywords
This publication has 27 references indexed in Scilit:
- Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic FeaturesJournal of Clinical Oncology, 2011
- Effect of Very Small Tumor Size on Cancer-Specific Mortality in Node-Positive Breast CancerJournal of Clinical Oncology, 2011
- Evidence for Cure by Adjuvant Therapy in Colon Cancer: Observations Based on Individual Patient Data From 20,898 Patients on 18 Randomized TrialsJournal of Clinical Oncology, 2009
- Identification of Patients with High-Risk Stage II Colon Cancer for Adjuvant TherapyDiseases of the Colon & Rectum, 2008
- Tumor size is associated with the systemic inflammatory response but not survival in patients with primary operable colorectal cancerJournal of Gastroenterology and Hepatology, 2007
- Should adjuvant chemotherapy become standard treatment for patients with stage II colon cancer?The Lancet Oncology, 2006
- Comparison of Multivisceral Resection and Standard Operation for Locally Advanced Colorectal Cancer: Analysis of Prognostic Factors for Short-Term and Long-Term OutcomeDiseases of the Colon & Rectum, 2004
- Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care’s Gastrointestinal Cancer Disease Site GroupJournal of Clinical Oncology, 2004
- Efficacy of Oral Adjuvant Therapy After Resection of Colorectal Cancer: 5-Year Results From Three Randomized TrialsJournal of Clinical Oncology, 2004
- Adjuvant Chemotherapy Use for Medicare Beneficiaries With Stage II Colon CancerJournal of Clinical Oncology, 2002